Printer Friendly

Perrigo unveils store brand version of nicorette mini nicotine lozenges in retail outlets.

M2 EQUITYBITES-January 23, 2013-Perrigo unveils store brand version of nicorette mini nicotine lozenges in retail outlets(C)2013 M2 COMMUNICATIONS http://www.m2.com

Healthcare product company The Perrigo Company (Nasdaq:PRGO) (Nasdaq:TASE) reported on Tuesday the start of over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavour) and 4 mg (mint flavour).

Today's launch represents the first to market nicotine mini lozenge products for the store brand market, said the company.

According to the company, its mint flavoured mini lozenges are marketed under retailer and wholesalers' store, or own brand labels and are comparable to GlaxoSmithKline's Nicorette Mini Lozenge.

The Perrigo Company's nicotine polacrilex mini lozenge is indicated to reduce withdrawal symptoms, including nicotine craving, associated with quitting smoking. Nicorette Mini Lozenge is selling at an annual rate estimated at over USD30m at all retail outlets.

((Comments on this story may be sent to info@m2.com)).END.PUB430>PDJanuary 23, 2013>JNM2 EQUITYBITES.PRICEDATENOT APPLICABLE.DAY

COPYRIGHT 2013 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jan 23, 2013
Words:160
Previous Article:Simba Energy opens new regional office in Kenya.
Next Article:Healthcare Trust of America Inc's board announces USD0.14375 per share dividend.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters